Domperidone effective in preventing rivastigmine-related gastrointestinal disturbances in patients with Alzheimer’s disease

OBJECTIVE: While acetylcholinesterase inhibitors, such as donepezil, galantamine, and rivastig-mine, are beneficial in treating behavioral symptoms of patients with Alzheimer’s disease (AD), their dose-limiting effects include gastrointestinal disturbances, such as nausea, vomiting, and diarrhea. We...

Descripción completa

Detalles Bibliográficos
Autores principales: Kano, Osamu, Urita, Yoshihisa, Ito, Hirono, Takazawa, Takanori, Kawase, Yuji, Murata, Kiyoko, Hirayama, Takehisa, Miura, Ken, Ishikawa, Yuichi, Kiyozuka, Tetsuhito, Aoyagi, Jo, Iwasaki, Yasuo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2013
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3788693/
https://www.ncbi.nlm.nih.gov/pubmed/24092978
http://dx.doi.org/10.2147/NDT.S50135

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3788693/
https://www.ncbi.nlm.nih.gov/pubmed/24092978
http://dx.doi.org/10.2147/NDT.S50135

Ejemplares similares